“Opioid substitution treatment (OST) increases the chances of people who inject drugs achieving good adherence to highly active antiretroviral therapy (HAART) by 68%, Canadian investigators report in the online edition of AIDS.
Researchers monitored 1852 people living with HIV, who were injecting drugs and who were eligible for HIV treatment, for an average of 5.5 years. They wanted to see if there was a causal relationship between OST and adherence to HIV treatment – at least 95% adherence assessed by pharmacy refill. After controlling for potential confounders, OST increased the odds of HIV treatment adherence by two-thirds, a finding that remained robust in a sensitivity analyses.
“This study demonstrates the substantial benefits of OST in linking HIV-positive opioid-dependent individuals into HAART in a universal healthcare setting with freely available HAART,” comment the authors. “There is a priority to expand access to OST particularly within HIV-positive populations, to optimize HIV treatment uptake and adherence and its subsequent individual and population health and economic benefits.”
Read more at: http://www.aidsmap.com/Opioid-substitution-treatment-increases-chances-that-people-who-inject-drugs-will-have-good-adherence-to-HIV-therapy/page/2959599/
Source: AidsMap.com – April 9, 2015